Literature DB >> 26104984

A single rapid point-of-care placental growth factor determination as an aid in the diagnosis of preeclampsia.

Ulla B Knudsen1, Camilla S Kronborg2, Peter von Dadelszen3, Ken Kupfer4, Seok-Won Lee4, Erik Vittinghus2, Jim G Allen2, Christopher W Redman5.   

Abstract

OBJECTIVES: To evaluate the clinical performance of a rapid point-of-care test, Triage PLGF (Alere, San Diego) in the diagnosis of preeclampsia. STUDY
DESIGN: For the reference range 2212 plasma samples were collected from 595 subjects with normotensive pregnancies, between week 17 of gestation and delivery. In the case-control part, two cohorts of women with preeclampsia (80 women) were matched for maternal age, gestational age (GA) at sampling and parity with normotensive women who delivered at 37weeks or more.
RESULTS: The areas under the receiver operating characteristic curves (GA<35weeks) were 1.0 and 0.994 (cohort 1 and 2, respectively). The clinical sensitivity of the Triage PLGF test for the pooled GA range of 21⩽GA<35, using a GA dependent cut-off, was 1.0 for both cohorts with specificities of 1.0 and 0.940.
CONCLUSIONS: The Triage PLGF test distinguishes well between preterm pregnancies with and without preeclampsia.
Copyright © 2011 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Biomarkers; PlGF; Preeclampsia; Preterm preeclampsia; Triage PLGF test

Year:  2011        PMID: 26104984     DOI: 10.1016/j.preghy.2011.08.117

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  14 in total

Review 1.  Molecular Mechanisms of Preeclampsia.

Authors:  Tammy Hod; Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

Review 2.  Leukocyte driven-decidual angiogenesis in early pregnancy.

Authors:  Patricia D A Lima; Jianhong Zhang; Caroline Dunk; Stephen J Lye; B Anne Croy
Journal:  Cell Mol Immunol       Date:  2014-07-28       Impact factor: 11.530

Review 3.  Prediction of preeclampsia-bench to bedside.

Authors:  Anjali Acharya; Wunnie Brima; Shivakanth Burugu; Tanvi Rege
Journal:  Curr Hypertens Rep       Date:  2014-11       Impact factor: 5.369

4.  Prenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsia, Pregnancy-induced Hypertension, and Proteinuria.

Authors:  H Lehnen; N Mosblech; T Reineke; A Puchooa; I Menke-Möllers; U Zechner; U Gembruch
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-05       Impact factor: 2.915

5.  Placental growth factor blunts uterine artery responses to angiotensin II.

Authors:  J Espinoza; A Betancourt; M A Belfort; A A Shamshirsaz; K A Fox; C Yallampalli
Journal:  BJOG       Date:  2019-03-18       Impact factor: 6.531

6.  Diagnostic accuracy of placental growth factor and ultrasound parameters to predict the small-for-gestational-age infant in women presenting with reduced symphysis-fundus height.

Authors:  M Griffin; P T Seed; L Webster; J Myers; L MacKillop; N Simpson; D Anumba; A Khalil; M Denbow; A Sau; K Hinshaw; P von Dadelszen; S Benton; J Girling; C W G Redman; L C Chappell; A H Shennan
Journal:  Ultrasound Obstet Gynecol       Date:  2015-07-03       Impact factor: 7.299

7.  Placental Growth Factor (PlGF) in Women with Suspected Pre-Eclampsia Prior to 35 Weeks' Gestation: A Budget Impact Analysis.

Authors:  Suzy Duckworth; Lucy C Chappell; Paul T Seed; Lucy Mackillop; Andrew H Shennan; Rachael Hunter
Journal:  PLoS One       Date:  2016-10-14       Impact factor: 3.240

8.  Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction.

Authors:  Jeanne Sibiude; Jean Guibourdenche; Marie-Danielle Dionne; Camille Le Ray; Olivia Anselem; Raphaël Serreau; François Goffinet; Vassilis Tsatsaris
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

9.  Comparison of placental growth factor and fetal flow Doppler ultrasonography to identify fetal adverse outcomes in women with hypertensive disorders of pregnancy: an observational study.

Authors:  Attila Molvarec; Nóra Gullai; Balázs Stenczer; Gergely Fügedi; Bálint Nagy; János Rigó
Journal:  BMC Pregnancy Childbirth       Date:  2013-08-13       Impact factor: 3.007

Review 10.  Placental Protein 13 (PP13) - A Placental Immunoregulatory Galectin Protecting Pregnancy.

Authors:  Nándor Gábor Than; Andrea Balogh; Roberto Romero; Eva Kárpáti; Offer Erez; András Szilágyi; Ilona Kovalszky; Marei Sammar; Sveinbjorn Gizurarson; János Matkó; Péter Závodszky; Zoltán Papp; Hamutal Meiri
Journal:  Front Immunol       Date:  2014-08-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.